MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC.
NASDAQ · Healthcare · Biotechnology · US
$6.97
−4.13%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.06
- Revenue estimate
- $43.7M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.02
- EPS estimate
- -$0.04
- Revenue actual
- $51.4M
- Revenue estimate
- $48.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -27.7%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $7.25
- PT range
- $6.50 – $8.00
- Analysts
- 2
1 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.04 | -$0.02 | Beat 54.05% | $51.4M |
| May 7, 2026 | -$0.05 | $0.01 | Beat 120.00% | $65.8M |
| Feb 25, 2026 | -$0.07 | -$0.25 | Miss -251.36% | $49.9M |
| Nov 6, 2025 | -$0.06 | -$0.08 | Miss -33.33% | $41.6M |
| Mar 18, 2025 | -$0.03 | -$0.06 | Miss -100.00% | $56.4M |
| Nov 7, 2024 | -$0.01 | -$0.02 | Miss -150.00% | $65.2M |
| Feb 22, 2024 | $0.00 | $0.01 | Beat 184.90% | $74.1M |
| Feb 22, 2023 | $0.34 | $0.35 | Beat 2.94% | $204.7M |
| Nov 2, 2022 | $0.32 | $0.37 | Beat 15.62% | $191.3M |
| Aug 4, 2022 | $0.45 | $0.54 | Beat 20.00% | $242.7M |
| May 5, 2022 | $0.44 | $0.54 | Beat 22.73% | $244.3M |
| Feb 23, 2022 | $0.38 | $0.45 | Beat 18.42% | $228.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026